Top

Medical and Surgical Lubricant Supply

Active

Federal

Response Deadline07/27/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 21

subcontract

Response DeadlineJul 27

Submission deadline

Response Deadline

07/27/2026, 05:00:00 PM UTCin 4 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Supply of surgical-grade lubricants in boxed units for federal medical use, compliant with FDA and hazardous materials regulations.

Similar Contracts

Same NAICS industry code

NAICS: 325412

New

DIBBS

Supply of Chloride Quantab Test Strips (High Range)The contract is for the procurement and delivery of high-range chloride test strips capable of measuring concentrations between 300 and 6000 mg/L, packaged in bottles containing 40 strips each. All products must fully comply with DLA medical standards governing packaging, labeling, and shelf life to ensure reliability and safety in medical supply chain applications. The solicitation is classified as a subcontract under NAICS code 325412 and is managed by the Medical Supply Chain MD Surg FSF under the Department of Defense. Performance is required at the designated location in Hampton, Virginia, with a zip code of 23665-2040. The opportunity was posted on July 22, 2026, and responses are due by July 28, 2026, with all submissions expected to meet the technical and regulatory requirements outlined by the agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

ZINC OXIDE OINTMENTZinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, is provided in collapsible tubes of 28.35 grams, with the unit of issue designated as a tube (TU). The product is regulated by the FDA and must comply with strict technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including packaging standards under MIL-STD-129 and commercial packaging per ASTM D3951 when non-hazardous, with DLA requirements superseding all other standards. Labeling must adhere to the latest Medical Marking Standard No. 1, and shelf life is fixed at 36 months without extension. Storage requires controlled room temperature not exceeding 30°C (86°F). The ointment is supplied by DYNAREX CORP under NDC 67777-0223-11 and part number 1190, with traceable shipping mandated and parcel post prohibited. Two delivery lines are specified: three tubes to Morrisville, NC with a July 24, 2026 delivery deadline and six tubes to Fort Bragg, NC with a July 27, 2026 deadline, both delivered FOB destination with zero quantity variance permitted. Inspection and acceptance occur at the delivery point, and packaging must meet DLA's RP001 packaging and palletization requirements. All shipments must include government-identifying information per contract specifications and be tracked through authenticated logistics channels.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

MULTIPLE ELECTROLYTThe contract specifies the procurement of Multiple Electrolytes Injection, Type 1, USP, in 500 mL bags, packaged in units of 24 per package, with a required shelf life of 18 months. No more than three months may have elapsed between the date of manufacture and the date of delivery to the government. The product is regulated by the FDA and must meet all applicable technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements, with packaging and marking strictly compliant with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a suitable container to prevent damage, and shipping containers must ensure safe, low-cost delivery to the point of delivery at Fort Bliss, Texas, with inspection and acceptance occurring at the destination. The item is identified by NSN 6505-01-462-5414 and manufacturer part number NDC00338-0221-03, produced by Baxter Healthcare Corp. The contract requires delivery within 20 days under FOB destination terms with zero variance allowed in quantity. The solicitation is issued under SPE2DP-26-T-4243 with a response deadline in July 2026, and the unit of issue is PG (package of 24), aligned to the DoD authorized unit. Additional provisions include handling of covered defense information and compliance with DLA’s packaging and labeling standards for medical acquisitions.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

FLUCONAZOLE TABLETSFluconazole Tablets 150 mg are supplied in individually sealed blister strips containing 12 tablets per strip, with the unit of issue defined as a package. The product must have a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Packaging must comply with commercial standards and be designed to protect the contents from damage or breakage, with exterior shipping containers suitable for safe transport at the lowest possible freight rate. All items must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and mercury or mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the supply except under specific exceptions for functional components like batteries or instruments, which must meet additional containment and shockproof requirements. The National Stock Number is 6505013953039, and the contract is issued under solicitation SPE2DP-26-T-4241 with delivery required FOB destination within 20 days. The quantity ordered is one package with zero variance allowed, and inspection and acceptance occur at the delivery point. The manufacturer identified is Golden State Medical Supply, Inc. with NDC 51407-0426-12, and ANIP Acquisition Co with NDC 62559-0992-12. Applicable technical and quality requirements are referenced from the DLA Master List, and the contract falls under the NAICS code 325412 for pharmaceutical manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DIBUCAINE OINTMENTDIBUCAINE OINTMENT USP, containing 1 percent dibucaine as the active ingredient, is supplied in a collapsible tube with a rectal applicator and is intended for rectal administration only, classified for external use. Each unit of issue is a single package containing one ounce or 28 grams of the ointment, with a non-extendable shelf life of 36 months and storage requirements between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is FDA-regulated and must comply with the DLA Master List of Technical and Quality Requirements, including MIL-STD-129 for marking and labeling, and packaging must adhere to RP001 for DLA procurement standards, with materials either packaged per IP025 if hazardous or ASTM D3951 if not, prioritizing DLA specifications over commercial standards. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, with a unit of issue in packages and quantity per unit pack of one. The contract SPE2DP-26-T-4234 specifies four separate line items totaling 11 packages, each priced at $2.00, with delivery due within 20 days of order, FOB destination, zero quantity variance allowed, and inspection and acceptance occurring at the delivery point. Shipments are directed to four distinct U.S. Navy vessel addresses in FPO locations, with explicit instructions to avoid parcel post and use only traceable freight methods via VSM. Required delivery dates span from May 29, 2026, to July 24, 2026, with specific RDD codes and project identifiers linked to each delivery. The product must be procured from the HARVARD DRUG GROUP, L.L.C., and all packaging, labeling, and shipping must strictly follow DLA technical and quality directives, including medical marking standards and palletization requirements, ensuring full compliance with federal procurement protocols.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJECTSodium Chloride 0.9% Injection, USP, in 250 mL bags, is being procured under solicitation SPE2DP-26-T-4240 with a unit of issue defined as a PG representing 24 bags, totaling one unit. The item is regulated by the FDA and must comply with strict packaging and marking standards as outlined in Medical Marking Standard No. 1, superseding MIL-STD-129; all units must be sealed in commercial containers that protect against damage and be packed in shipping containers suitable for safe delivery at the lowest cost to Fort Bliss, Texas, under FOB destination terms. The product has a non-extendable shelf life of 24 months and requires storage at room temperature of 25°C, with brief exposure up to 40°C permitted without compromising integrity. Multiple manufacturers and distributors are listed with their respective part numbers, including B. Braun Medical Inc., Trillamed LLC, and Cardinal Health, all producing the same NDC 00264-7800-20 formulation. The contract requires strict adherence to DLA’s Technical and Quality Requirements referenced in the Master List, and all supplies must be delivered within 20 days of award with no variance allowed in quantity. The solicitation closed on July 28, 2026, and is managed by the Department of Defense’s Medical Supply Chain under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ANESTHESIA SET, EPIDURAThe anesthesia set is an epidural kit equipped with a 20-gauge catheter and a 17-gauge Tuohy Schliff winged needle, containing a total of 29 components per package. Each unit of issue is a package containing ten individual sets, and all items must have a shelf life of twelve months from the date of manufacture. No more than two months may elapse between the date of manufacture and the date of delivery to the government to ensure product freshness and safety. The product is identified by NSN 6515-01-323-6531 and is required in a quantity of one package under purchase request 7017577639. All bids must specify the source and part number of the supplied item. The contract is governed by technical and quality requirements from the DLA Master List, with compliance determined by the revision in effect as of the solicitation issue date or award date. Packaging must meet DLA requirements, and any non-accepted supplies must have government identification removed prior to return. The solicitation number is SPE2DS-26-T-260Y, issued on July 22, 2026, with responses due by July 28, 2026. The place of performance is JBER, Alaska, 99506-4400, and the point of contact is James Burke, reachable via email or phone provided. The National Institute of Standards and Technology classification code is 325412, indicating medical device manufacturing. Delivery is required within five days of award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

FLUORESCEIN SODIUM OPHFluorescein Sodium Ophthalmic Strips, USP, are procured under contract SPE2DP-26-T-4239 with strict packaging and labeling requirements mandated by the Defense Logistics Agency. Each unit consists of 100 individually sealed strips containing 1 mg of fluorescein sodium, packed in commercial containers designed to prevent damage or breakage, with exterior shipping containers meeting carrier standards for safe and cost-effective delivery to the designated destination. All items must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and bear required markings including NSN, manufacturer, CAGE code, manufacture date, expiration date, contract number, and lot number. The product has a non-extendable shelf life of 36 months classified as a TYPE I (CODE Q) item. Mercury or mercury-containing compounds are prohibited from intentional addition or direct contact with the product except in specified exceptions such as functional components in batteries or instruments, with portable lamps or instruments containing mercury requiring shock-proof construction and secondary containment per NAVSEA 5100-003D. Suppliers must submit Safety Data Sheets (SDS) and Hazard Communication Standard labels compliant with 29 C.F.R. 1910.1200 prior to award, and ensure employee training on the Globally Harmonized System requirements. The item is regulated by the FDA, and buyers must submit referrals through EBS for confirmation. Delivery is FOB destination within 20 days, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is one package (PG), representing 100 strips, and procurement is governed by DLA’s technical and quality requirements outlined in their Master List.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPIHydrogen Peroxide Topical Solution, USP, is being procured as a 3% stabilized topical solution for external use only, with a unit of issue defined as a 473-milliliter bottle (1 pint). The product is regulated by the FDA and must comply with all labeling and marking requirements specified in Medical Marking Standard No. 1, dated February 4, 2013, which supersedes MIL-STD-129. Each unit must be packaged in a sealed commercial container that protects against damage and breakage, with exterior shipping containers suitable for safe transport via common carrier at the lowest cost to the delivery point. Storage instructions require keeping the solution tightly closed at controlled room temperature, protected from freezing and excessive heat, with no shaking of the bottle and a maximum usage duration of one week. The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) item per RS016 requirements. Suppliers must submit Safety Data Sheets (SDS) and Hazard Communication Standard (HCS) labels compliant with 29 C.F.R. 1910.1200, effective June 1, 2015, and must train employees on these updated safety protocols. The procurement is under solicitation SPE2DP-26-T-4245 with a response deadline of July 28, 2026, and delivery is required FOB destination within 20 days. Quantity is fixed at 3 bottles with zero variance allowed, and the NSN is 6505-00-153-8480. Only approved manufacturers including Cardinal Health, Medline Industries, and McKesson Medical-Surgical are referenced as eligible suppliers. All requisitions under DMLIIS ID 1721935 are canceled without replacement as part of a change in acquisition classification from ACC-L to ACCY.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing – Progesterone Capsules

POSTED

DEADLINE

Progesterone CapsulesThe solicitation SPE2D2-26-R-0015 seeks offers for Progesterone Capsules under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. Issued by the Department of Defense through DLA Troop Support, this procurement is managed by the office located in Philadelphia, Pennsylvania, with the primary point of contact being Christopher Newman, reachable via phone and email. The solicitation was posted on July 22, 2026, and responses are due by August 21, 2026, at 7:00 PM Eastern Time. The contract does not specify a set-aside type, indicating it is open to all eligible offerors without restricted competition. The place of performance details are not provided, suggesting delivery may be coordinated with standard DLA logistics channels. Interested parties must submit proposals through the SAM.gov portal, following the guidelines outlined in the solicitation document.

POSTED

DEADLINE

Pharmaceutical Packaging and Labeling ServicesThe contract entails custom packaging and labeling of ibuprofen tablets to comply with federal logistics standards, requiring adherence to specific identifiers such as NSN, NDC, CAGE, and TCN to ensure proper tracking and distribution within government supply chains. The work is performed under a subcontract and falls under NAICS code 325412 for pharmaceutical preparation manufacturing, with the Defense Logistics Agency acting as the overseeing entity under the Department of Defense. Packaging must meet stringent regulatory and logistical requirements to support military and federal healthcare operations, with delivery expected to align with the contract award number SPE2DP26F7911 and the associated procurement framework governed by the DLA’s systems. The contract was posted on July 21, 2026, and performance is expected to be carried out in accordance with federal guidelines without specified geographic constraints.

Defense Logistics Agency

POSTED

2 days ago

DEADLINE

N/A

View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210

New

DIBBS

ALBUTEROL INHALATIOAlbuterol Inhalation Aerosol is a pressurized aluminum canister containing 60 actuations, each delivering 108 micrograms of albuterol sulfate, equivalent to 90 micrograms of albuterol base, via a plastic actuator with a strapcap and integrated counter. The product is prescribed for oral inhalation only and is classified as an institutional pack with a net canister weight of 8 grams. It must be stored at 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F), and must always be kept with the mouthpiece down. The inhaler must be shaken well before each use and brought to room temperature prior to administration for optimal performance. The item has a non-extendable shelf life of 18 months, and at the time of receipt by the first government activity, it must have a minimum of 15 months of remaining shelf life. The product is hazardous due to its pressurized contents and flammable characteristics, and it must not be punctured, exposed to temperatures above 120°F, or disposed of in fire or incinerators. Packaging must comply with hazardous materials regulations including 49 CFR and ICAO standards, and a current Material Safety Data Sheet (MSDS) must accompany each shipment and be submitted via DLA’s designated email. Labeling and marking must adhere to SPE2DP-26-T-4242 and Medical Marking Standard No. 1C. The item is regulated by the FDA, and procurement requires referral confirmation through EBS. Packaging and technical requirements are governed by DLA specifications, including RD003, RA001, and RP001, and the NSN is 6505-01-649-7928. The purchase request is for 10 units with delivery expected within 20 days.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

SUMATRIPTAN SUCCINATESumatriptan Succinate Tablets 100mg are procured under solicitation SPE2DP-26-T-4238 for acute treatment of migraine with or without aura in adults. The product must be supplied in bottles of nine tablets, stored at 20 to 25°C (68 to 77°F), protected from light, and adhere to a strict 24-month non-extendable shelf life as a Type I (Code M) medical item. Packaging and marking must comply with MIL-STD-2073-1E, MIL-STD-129, and DLA’s Medical Marking Standard No. 1, with palletization governed by DLA Packaging Requirements. The item is subject to FDA regulation and requires referral through EBS for confirmation. Two contract line items are listed: one for one bottle and another for five bottles, both with identical specifications, delivered FOB destination within five days, with no variance in quantity allowed. Delivery is directed to JBER, Alaska, with designated shipping and parcel post addresses provided. The required delivery date is July 24, 2026, and the contract includes detailed logistics codes, unit of issue references, and procurement identifiers. Manufacturer identifiers include NDC codes for Mylan Pharmaceuticals Inc and Golden State Medical Supply, Inc., and all technical and quality requirements referenced must align with the DLA Master List at the time of solicitation or award.

Medicinal and Botanical Manufacturing

POSTED

DEADLINE

IOPAMIDOL INJECTIONIopamidol Injection, identified by NSN 6505-01-657-0664 and NDC 00270-1316-35, is a non-intrathecal contrast agent supplied in ten 100 mL single-dose bottles per package, with a shelf life of 24 months that is non-extendable and classified as a Type I Code M item. The product must be stored at 20 to 25°C (68 to 77°F) and protected from light, in compliance with USP standards. Packaging and marking must adhere strictly to Medical Marking Standard No. 1, which replaces all references to MIL-STD-129, and each unit must be sealed in a container that prevents damage or breakage, with outer shipping containers ensuring safe, cost-effective delivery via common carrier to the destination. The item is subject to Federal Acquisition Regulation requirements for medical acquisitions, including commercial packaging standards, and is classified under hazardous materials handling protocols due to its nature. Delivery is required FOB destination within five days of contract award, with zero tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The contract, issued under solicitation SPE2DP-26-T-4236 by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, is for one package with delivery required by July 24, 2026, and is managed by Bracco Diagnostics Inc. with technical and quality requirements referenced from the DLA Master List. All logistics, labeling, and compliance must conform to DLA specifications, and the point of contact for inquiries is Timothy McCauley at DLA.

Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

DEADLINE

LIDOCAINE HYDROCHLOLidocaine Hydrochloride and Epinephrine, USP, is a parenteral injectable medication containing a 2 percent concentration of lidocaine hydrochloride and a 1:50,000 dilution of epinephrine bitartrate, supplied in 1.7 mL cartridges. The contract specifies delivery of 50 cartridges per package, with each package consisting of five blisters of ten cartridges each, housed in cardboard boxes. The product must be stored at controlled room temperature below 25°C (77°F), protected from light, and must not be frozen. It is subject to an 18-month non-extendable shelf life and must be labeled and marked in accordance with Medical Marking Standard No. 1, superseding all references to MIL-STD-129. The item is regulated by the FDA, and procurement requires confirmation via EBS referral before award. The unit of issue is a package, and delivery must occur within five days FOB destination, with no variance allowed in quantity. Packaging must comply with commercial standards and be suitable for safe transport by common carrier, with all units sealed and protected against damage. The delivery point is Joint Base Elmendorf-Richardson, Alaska, and the contract is assigned NSN 6505-01-576-2767 under solicitation SPE2DP-26-T-4237, with a required delivery date of July 24, 2026.

Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

POSTED

DEADLINE

PSYLLIUM HYDROPHILIThe contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12 gram packets, each containing 25 mg potassium and 5 mg sodium, packaged in units of 30 packets per package, with a total requirement of 19,000 packets across multiple CLINs. The item is regulated by the FDA and must be supplied with the manufacturer’s part number NDC37000-0740-87 under The Procter & Gamble Distributing LLC. The product has a non-extendable shelf life of 24 months, and all packaging must comply with the latest Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be labeled in accordance with DLA packaging requirements. Each unit must be sealed in a protective container and packed in commercial shipping containers suitable for safe transport by common carrier at the lowest cost. Delivery is FOB destination with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The contract requires precise marking, palletization, and traceable shipping methods, explicitly prohibiting parcel post. Delivery schedules vary by CLIN and are set between June 2025 and July 2026, with fulfillment addressed to multiple DoD locations including Camp Pendleton, Camp Kinsler, and the USS Pinckney. Bidders must specify their source and part number, and the contracting officer must refer the bid to a product specialist for FDA-regulated item confirmation. Technical and quality requirements are governed by the DLA Master List, and all documentation must align with the version in effect on the solicitation or award date.

Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in 5 days

View Details